Evaluation of C-ErbB-2 Overexpression and Her-2/neu Gene Copy Number Heterogeneity in Barrett’s Adenocarcinoma
Amplifiction of the Her-2/neu gene is accompanied by overexpression of its cell surface receptor product, c‐erbB‐2 protein. To investigate the degree of intratumoural heterogeneity we applied immunohistochemistry in primary Barrett’s adenocarcinoma (BCA) (n = 6) and dysplasia adjacent to the carcino...
Saved in:
| Main Authors: | Axel Walch, Karin Bink, Peter Gais, Stefan Stangl, Peter Hutzler, Michaela Aubele, James Mueller, Heinz Höfler, Martin Werner |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2000-01-01
|
| Series: | Analytical Cellular Pathology |
| Online Access: | http://dx.doi.org/10.1155/2000/947249 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
erbB2 Overexpression in Uterine Serous Cancer: A Molecular Target for Trastuzumab Therapy
by: Karim S. ElSahwi, et al.
Published: (2011-01-01) -
Clinicopathological value of ErbB2 gene and protein expression in osteochondroma
by: Zhen Huang, et al.
Published: (2020-01-01) -
Combined inhibition of ErbB1/2 and Notch receptors effectively targets breast ductal carcinoma in situ (DCIS) stem/progenitor cell activity regardless of ErbB2 status.
by: Gillian Farnie, et al.
Published: (2013-01-01) -
Prefrontal ErbB4-positive interneurons for avoidance
by: Wanpeng Cui, et al.
Published: (2025-05-01) -
Ligand‐dependent responses of the ErbB signaling network: experimental and modeling analyses
by: Marc R Birtwistle, et al.
Published: (2007-11-01)